The small molecule DGP has great potential for preclinical studies and the ability to inhibit ZIKV infection in humans.
No takes yet. Share an insight, caveat, or question.
Martínez‐López et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: